Dr. Nitesh Rohatgi

MBBS, MD (General Medicine), MRCP (UK), Fellow (Medical Oncology – UK)

Senior Director – Department of Medical Oncology

22+ Years of Experience
Gurgaon

Dr. Nitesh Rohatgi is an internationally acclaimed Medical Oncologist with more than 22 years of elite clinical experience spanning both the United Kingdom and India. After completing his undergraduate medical degrees in India, he spent over a decade within the British healthcare ecosystem, earning his MRCS/MRCP and completing advanced medical oncology training at the world-renowned Oxford University Hospitals, UK. Dr. Rohatgi is widely recognized as a leading authority in molecular targeted therapies, precision immunotherapy, and breast cancer oncology. His clinical practice is firmly anchored in evidence-based transatlantic oncology protocols, prioritizing low-toxicity treatments and a customized patient-first approach.

  • Precision Immunotherapy: Deploying advanced immune checkpoint inhibitors tailored to specific molecular tumor markers.
  • Breast Oncology: Tailored targeted therapies, endocrine treatments, and personalized chemotherapy for all stages of breast cancer.
  • Gastrointestinal & Lung Malignancies: Advanced medical management for colorectal, gastric, pancreatic, and non-small cell lung cancers.
  • Gynaecological Cancers: Comprehensive systemic treatment tracks for advanced ovarian, cervical, and uterine malignancies.
  • Served with distinction as a Consultant Medical Oncologist at premier NHS hospitals in the United Kingdom before returning to India.
  • Held top clinical leadership positions, serving as Director of Medical Oncology at Max Super Speciality Hospital, Saket, prior to joining Fortis.
  • Actively involved as a principal investigator in multiple international Phase II and Phase III oncology clinical trials, contributing to global cancer research.
  • Fellow of the Royal College of Physicians (FRCP) and permanent member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).
  • Highly published author with numerous scientific papers in high-impact international oncology journals, shaping modern precision oncology models.